Cargando…

A Genome Wide Meta-Analysis Study for Identification of Common Variation Associated with Breast Cancer Prognosis

OBJECTIVE: Genome wide association studies (GWAs) of breast cancer mortality have identified few potential associations. The concordance between these studies is unclear. In this study, we used a meta-analysis of two prognostic GWAs and a replication cohort to identify the strongest associations and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rafiq, Sajjad, Khan, Sofia, Tapper, William, Collins, Andrew, Upstill-Goddard, Rosanna, Gerty, Susan, Blomqvist, Carl, Aittomäki, Kristiina, Couch, Fergus J., Liu, Jianjun, Nevanlinna, Heli, Eccles, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272267/ https://www.ncbi.nlm.nih.gov/pubmed/25526632 http://dx.doi.org/10.1371/journal.pone.0101488

Ejemplares similares

Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer
por: Khan, Sofia, et al.
Publicado: (2017)

Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
por: Kadalayil, Latha, et al.
Publicado: (2017)

Support Vector Machine Classifier for Estrogen Receptor Positive and Negative Early-Onset Breast Cancer
por: Upstill-Goddard, Rosanna, et al.
Publicado: (2013)

Comprehensive analysis of NuMA variation in breast cancer
por: Kilpivaara, Outi, et al.
Publicado: (2008)

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Pathogenic Variant Spectrum in Breast Cancer Risk Genes in Finnish Patients
por: Nurmi, Anna K., et al.
Publicado: (2022)

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families
por: Pelttari, Liisa M, et al.
Publicado: (2015)

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2008)

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
por: Muranen, Taru A., et al.
Publicado: (2016)

Variants on the promoter region of PTEN affect breast cancer progression and patient survival
por: Heikkinen, Tuomas, et al.
Publicado: (2011)

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
por: Muranen, Taru A, et al.
Publicado: (2011)

ATM variants and cancer risk in breast cancer patients from Southern Finland
por: Tommiska, Johanna, et al.
Publicado: (2006)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
por: Hallamies, Sanna, et al.
Publicado: (2017)

BACH1 Ser919Pro variant and breast cancer risk
por: Vahteristo, Pia, et al.
Publicado: (2006)

MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
por: Peurala, Hanna, et al.
Publicado: (2011)

Quantifying the cumulative effect of low-penetrance genetic variants on breast cancer risk
por: Smyth, Conor, et al.
Publicado: (2015)

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer
por: Alhopuro, Pia, et al.
Publicado: (2020)

Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients
por: Nurmi, Anna, et al.
Publicado: (2019)

Familial Breast Cancer in Southern Finland
por: Eerola, Hannaleena, et al.
Publicado: (1999)

NTHL1 is a recessive cancer susceptibility gene
por: Nurmi, Anna K., et al.
Publicado: (2023)

SNPs in lncRNA Regions and Breast Cancer Risk
por: Suvanto, Maija, et al.
Publicado: (2020)

Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility
por: Low, Yen Ling, et al.
Publicado: (2010)

High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome
por: Jamshidi, Maral, et al.
Publicado: (2021)

Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
por: Arason, Adalgeir, et al.
Publicado: (2010)

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
por: Li, Yuqing, et al.
Publicado: (2011)

FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome
por: Kiiski, Johanna I., et al.
Publicado: (2016)

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
por: Kiiski, Johanna I., et al.
Publicado: (2017)

The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer
por: Tapper, William, et al.
Publicado: (2008)

A genome-wide association scan on estrogen receptor-negative breast cancer
por: Li, Jingmei, et al.
Publicado: (2010)

High cyclin B1 expression is associated with poor survival in breast cancer
por: Aaltonen, K, et al.
Publicado: (2009)

Mast cells and eosinophils in invasive breast carcinoma
por: Amini, Rose-Marie, et al.
Publicado: (2007)

Identification of genetic markers with synergistic survival effect in cancer
por: Louhimo, Riku, et al.
Publicado: (2013)

The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients
por: Fagerholm, Rainer, et al.
Publicado: (2015)

Effect of image compression and scaling on automated scoring of immunohistochemical stainings and segmentation of tumor epithelium
por: Konsti, Juho, et al.
Publicado: (2012)

Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes
por: Christodoulou, Katja, et al.
Publicado: (2013)

High-grade ER-negative tumour breast cancers are characteristic of both very young onset cases and patients with hereditary breast cancer
por: Eccles, D, et al.
Publicado: (2006)

Deleterious coding variants in multi-case families with non-syndromic cleft lip and/or palate phenotypes
por: Pengelly, Reuben J., et al.
Publicado: (2016)

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
por: Seibold, Petra, et al.
Publicado: (2015)

Other short opinions/comments on moderate/low cancer genetic risk markers in medical practice and the article Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology by Lubinski et al., Breast Cancer Res Treat 2008 Apr 15
por: Aittomäki, Kristiina
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ns1d1nbeg7q9d950lmt86fp9n6